Bambul Heck P, Eicken A, Kasnar-Samprec J, Ewert P, Hager A
Department of Paediatric Cardiology and Congenital Heart Disease, Deutsches Herzzentrum München (DHM), Technische Universität München (TUM), Germany.
Department of Cardiovascular Surgery, Deutsches Herzzentrum München (DHM), Technische Universität München (TUM), Germany.
Int J Cardiol. 2017 Feb 1;228:313-318. doi: 10.1016/j.ijcard.2016.11.056. Epub 2016 Nov 9.
Pulmonary arterial hypertension (PAH) is virtually absent after closure of ventricular septal defect (VSD) in the first six months of life. However the prevalence of PAH in patients, who underwent VSD closure later, is not clear. The aim of this study was to analyse the prevalence of PAH after a successful VSD closure after the age of 6months and whether there are risk factors for developing PAH.
Echocardiographic and right heart catheter data of patients with VSD or complete atrioventricular septal defect, who underwent VSD closure after the age of 6months in our institution between 01/2005 and 06/2014, were retrospectively analyzed. PAH was defined as mean pulmonary arterial pressure (mPAP) of ≥25mmHg or tricuspid regurgitation jet velocity of ≥3.5m/s.
In 228 patients (median age at shunt closure 4.0years, range 0.5-69) and 174 complete follow-up data (median follow-up 3.7years, range 0.5-39.4), 9 patients needed pulmonary vasodilator therapy after shunt closure, 4 of them temporarily for up to 79months. Three patients are still on vasodilator treatment 1, 2.6 and 6years after surgery, other two were lost to follow-up. Another 6 patients with preoperatively borderline hemodynamics due to elevated mPAP and pulmonary vascular resistance, recovered well without signs of postoperative PAH.
With the current practice for safe late VSD closure, PAH is very rare at least in the first years of follow-up. In most patients with perioperative PAH, this condition appears to be transient and shows good response on pulmonary vasodilator treatment.
在出生后的前六个月内关闭室间隔缺损(VSD)后,几乎不会出现肺动脉高压(PAH)。然而,对于后来接受VSD关闭手术的患者,PAH的患病率尚不清楚。本研究的目的是分析6个月龄后成功关闭VSD后PAH的患病率,以及是否存在发生PAH的危险因素。
回顾性分析了2005年1月至2014年6月间在我院6个月龄后接受VSD关闭手术的室间隔缺损或完全房室间隔缺损患者的超声心动图和右心导管数据。PAH定义为平均肺动脉压(mPAP)≥25mmHg或三尖瓣反流喷射速度≥3.5m/s。
在228例患者(分流关闭时的中位年龄为4.0岁,范围为0.5 - 69岁)和174例完整的随访数据(中位随访时间为3.7年,范围为0.5 - 39.4年)中,9例患者在分流关闭后需要进行肺血管扩张剂治疗,其中4例患者临时治疗长达79个月。3例患者在术后1年、2.6年和6年仍在接受血管扩张剂治疗,另外2例失访。另外6例术前因mPAP和肺血管阻力升高而血流动力学临界的患者恢复良好,无术后PAH迹象。
按照目前安全的晚期VSD关闭手术方法,至少在随访的头几年,PAH非常罕见。在大多数围手术期PAH患者中,这种情况似乎是暂时的,并且对肺血管扩张剂治疗反应良好。